CMFRI, Library (2022) And now, a seaweed-based nutraceutical cure for fatty liver disease Business Standard dated 27th September 2022. Business Standard.
|
Text
Business Standard_27-09-2022.pdf Download (155kB) | Preview |
Official URL: https://www.business-standard.com/article/current-...
Related URLs:
Abstract
Kochi: The Central Marine Fisheries Research Institute (CMFRI) based in Kochi has come up with a nutraceutical product from select seaweeds for the treatment of non-alcoholic fatty liver disease (NAFLD). Named Cadalmin LivCure extract, the product is a unique blend of 100 percent natural bioactive ingredients extracted from seaweeds to improve liver health.
| Item Type: | Article |
|---|---|
| Subjects: | Algae > Seaweed CMFRI News Clippings |
| Divisions: | Library and Documentation Centre |
| Depositing User: | Mr. Augustine Sipson N A |
| Date Deposited: | 03 Oct 2022 04:08 |
| Last Modified: | 03 Oct 2022 04:08 |
| URI: | http://eprints.cmfri.org.in/id/eprint/16294 |
Actions (login required)
 |
View Item |
Altmetric
Altmetric